Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 17,360 shares at $5.81 ($101K) on 2019-09-23, disclosed to the SEC on 2019-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.81 | 8,680 | $50K | 50.0% |
| 2 | $5.81 | 8,680 | $50K | 50.0% |
| Total | $5.81 avg | 17,360 | $101K | 100% |
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |